Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

Sitafloxacin-based triple therapy achieved 83.6% (per-protocol) and 78.2% (intention-to-treat) success in eradicating Helicobacter pylori among 78 Japanese patients after clarithromycin-based first-line and metronidazole-based second-line triple therapies failed. Eradication succeeded in 32 out of 4...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Matsuzaki, Juntaro, Suzuki, Hidekazu, Nishizawa, Toshihiro, Hirata, Kenro, Tsugawa, Hitoshi, Saito, Yoshimasa, Okada, Sawako, Fukuhara, Seiichiro, Hibi, Toshifumi
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2012
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294878/
https://ncbi.nlm.nih.gov/pubmed/22203601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05941-11
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky